Fosun Pharma USA Announces Abstract to be Presented at IASLC 2023 North America Conference on Lung Cancer (NACLC) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Fosun Pharma USA Inc. ("Fosun Pharma USA") announced today its abstract on ASTRIDE (NCT05468489), a phase 3 randomized, open-label study of.